NeuroPace (NPCE) Price to Sales (2021 - 2026)

NeuroPace has reported Price to Sales for 6 years, with the latest figure at 23.87 in Q2 2026.

• On a quarterly basis, Price to Sales rose 26.43% year-over-year to 23.87 in Q2 2026; TTM through Jun 2026 was 5.51, a 26.6% increase from a year earlier, with the FY2025 full-year figure at 5.18, up 22.82% from the prior year.
• Price to Sales was 23.87 for Q2 2026 at NeuroPace, up from 20.21 in the prior quarter.
• The five-year high for Price to Sales was 23.87 in Q2 2026, with the low at 2.92 in Q4 2022.
• Average Price to Sales over 5 years is 14.36, with a median of 15.63 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Price to Sales slumped 80.83% in 2022, then surged 445.79% in 2023.
• Over 5 years, Price to Sales stood at 2.92 in 2022, then soared by 445.79% to 15.93 in 2023, then slipped by 1.33% to 15.71 in 2024, then grew by 24.07% to 19.5 in 2025, then gained by 22.4% to 23.87 in 2026.
• The last three Price to Sales figures came in at 23.87 (Q2 2026), 20.21 (Q1 2026), and 19.5 (Q4 2025), per Business Quant data.